Changing Prevalence and Treatment Outcomes of Patients with p16 Human Papillomavirus Related Oropharyngeal Squamous Cell Carcinoma in New Zealand

There has, to our knowledge, been no previous report of changes in the prevalence and outcomes of treatment of HPV-positive (+) oropharyngeal squamous cell carcinoma (SCC) in New Zealand. We identified all affected patients in the greater Wellington region between 1 January 1994 and 30 November 2014 from the New Zealand Cancer Registry. Their personal details, characteristics of their tumours, treatment, complications, and outcomes were collected retrospectively from their casenotes and the New Zealand Death Registry, followed by p16 immunohistochemical staining.

from #ENT via xlomafota13 on Inoreader http://ift.tt/292WNea
via IFTTT